Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2573392rdf:typepubmed:Citationlld:pubmed
pubmed-article:2573392lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2573392lifeskim:mentionsumls-concept:C0005821lld:lifeskim
pubmed-article:2573392lifeskim:mentionsumls-concept:C0018338lld:lifeskim
pubmed-article:2573392lifeskim:mentionsumls-concept:C0028193lld:lifeskim
pubmed-article:2573392lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:2573392lifeskim:mentionsumls-concept:C0060556lld:lifeskim
pubmed-article:2573392pubmed:issue2lld:pubmed
pubmed-article:2573392pubmed:dateCreated1990-1-8lld:pubmed
pubmed-article:2573392pubmed:abstractTextSodium nitroprusside, an activator of the soluble guanylate cyclase, inhibits the intracellular Ca2+ mobilization, ATP secretion and aggregation of human platelets evoked by fluoroaluminate. Similar results are obtained with 8-bromo-cyclic GMP (8-Br-cGMP). Both nitroprusside and 8-Br-cGMP inhibit the protein kinase C-dependent phosphorylation of the 47 and 20 kDa proteins induced by fluoroaluminate, but not by the protein kinase C activators phorbol ester and diacylglycerol. Since fluoroaluminate interacts directly with a G protein, the present results suggest that the cGMP interferes with platelet activation at the level of G protein-phospholipase C.lld:pubmed
pubmed-article:2573392pubmed:languageenglld:pubmed
pubmed-article:2573392pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2573392pubmed:citationSubsetIMlld:pubmed
pubmed-article:2573392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2573392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2573392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2573392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2573392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2573392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2573392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2573392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2573392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2573392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2573392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2573392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2573392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2573392pubmed:statusMEDLINElld:pubmed
pubmed-article:2573392pubmed:monthNovlld:pubmed
pubmed-article:2573392pubmed:issn0006-3002lld:pubmed
pubmed-article:2573392pubmed:authorpubmed-author:DeanaRRlld:pubmed
pubmed-article:2573392pubmed:authorpubmed-author:AlexandreAAlld:pubmed
pubmed-article:2573392pubmed:authorpubmed-author:ZoccaratoFFlld:pubmed
pubmed-article:2573392pubmed:authorpubmed-author:DoniM GMGlld:pubmed
pubmed-article:2573392pubmed:authorpubmed-author:RuzzeneMMlld:pubmed
pubmed-article:2573392pubmed:issnTypePrintlld:pubmed
pubmed-article:2573392pubmed:day20lld:pubmed
pubmed-article:2573392pubmed:volume1014lld:pubmed
pubmed-article:2573392pubmed:ownerNLMlld:pubmed
pubmed-article:2573392pubmed:authorsCompleteYlld:pubmed
pubmed-article:2573392pubmed:pagination203-6lld:pubmed
pubmed-article:2573392pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:2573392pubmed:meshHeadingpubmed-meshheading:2573392-...lld:pubmed
pubmed-article:2573392pubmed:meshHeadingpubmed-meshheading:2573392-...lld:pubmed
pubmed-article:2573392pubmed:meshHeadingpubmed-meshheading:2573392-...lld:pubmed
pubmed-article:2573392pubmed:meshHeadingpubmed-meshheading:2573392-...lld:pubmed
pubmed-article:2573392pubmed:meshHeadingpubmed-meshheading:2573392-...lld:pubmed
pubmed-article:2573392pubmed:meshHeadingpubmed-meshheading:2573392-...lld:pubmed
pubmed-article:2573392pubmed:meshHeadingpubmed-meshheading:2573392-...lld:pubmed
pubmed-article:2573392pubmed:meshHeadingpubmed-meshheading:2573392-...lld:pubmed
pubmed-article:2573392pubmed:meshHeadingpubmed-meshheading:2573392-...lld:pubmed
pubmed-article:2573392pubmed:meshHeadingpubmed-meshheading:2573392-...lld:pubmed
pubmed-article:2573392pubmed:meshHeadingpubmed-meshheading:2573392-...lld:pubmed
pubmed-article:2573392pubmed:meshHeadingpubmed-meshheading:2573392-...lld:pubmed
pubmed-article:2573392pubmed:meshHeadingpubmed-meshheading:2573392-...lld:pubmed
pubmed-article:2573392pubmed:meshHeadingpubmed-meshheading:2573392-...lld:pubmed
pubmed-article:2573392pubmed:meshHeadingpubmed-meshheading:2573392-...lld:pubmed
pubmed-article:2573392pubmed:meshHeadingpubmed-meshheading:2573392-...lld:pubmed
pubmed-article:2573392pubmed:year1989lld:pubmed
pubmed-article:2573392pubmed:articleTitleCyclic GMP and nitroprusside inhibit the activation of human platelets by fluoroaluminate.lld:pubmed
pubmed-article:2573392pubmed:affiliationDepartment of Biological Chemistry, C.N.R. Unit for the Study of Mitochondrial Physiology, University of Padova, Italy.lld:pubmed
pubmed-article:2573392pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2573392lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2573392lld:pubmed